Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | PDE4A | P27815 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | PRKCA | P17252 | 1/20 | 0.34 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.34 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.34 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2673586 | 1.00 | LMNA (0.44) | LMNAL3MBTL1TDP1PDE4AKDM4E | |
| SCHEMBL18877227 | 0.96 | LMNA (0.40) | LMNAL3MBTL1TDP1PDE4AKDM4E | |
| SCHEMBL4607362 | 0.96 | LMNA (0.40) | LMNAL3MBTL1TDP1PDE4AKDM4E | |
| SCHEMBL27114700 | 0.92 | NAAA (0.40) | LMNATDP1KDM4EDUSP3MEN1 | |
| SCHEMBL27114713 | 0.92 | NAAA (0.40) | LMNATDP1KDM4EDUSP3MEN1 | |
| SCHEMBL8965490 | 0.88 | KDM4E (0.42) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL24586199 | 0.87 | NAAA (0.40) | LMNATDP1KDM4EDUSP3MEN1 | |
| SCHEMBL27114692 | 0.87 | NAAA (0.40) | LMNATDP1KDM4EDUSP3MEN1 | |
| SCHEMBL4605267 | 0.85 | LMNA (0.49) | LMNAL3MBTL1TDP1PDE4AKDM4E | |
| SCHEMBL8437390 | 0.84 | LMNA (0.37) | LMNAL3MBTL1TDP1PDE4AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1942872-A2 | CARBOXYALKYLCELLULOSE ESTERS FOR ADMINISTRATION OF POORLY SOLUBLE PHARMACEUTICALLY ACTIVE AGENTS | EASTMAN CHEMICAL COMPANY (US) | 2008-07-16 | — | — | EP | disclosed |
| US-20070178152-A1 | Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents | EASTMAN CHEMICAL COMPANY | 2007-08-02 | — | — | US | disclosed |
| WO-2007056205-A2 | CARBOXYALKYLCELLULOSE ESTERS FOR ADMINISTRATION OF POORLY SOLUBLE PHARMACEUTICALLY ACTIVE AGENTS | EASTMAN CHEMICAL COMPANY (US) | 2007-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070178152-A1 | Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents | CEL, LIPA, SI | LMNA 3005/4885L3MBTL1 3929/4885TDP1 1183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.